Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Bioinorganic Chemistry and Applications, enter your email address in the box below.

Bioinorganic Chemistry and Applications
Volume 2013 (2013), Article ID 565032, 12 pages
http://dx.doi.org/10.1155/2013/565032
Research Article

Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands

Yan Peng, Min-Min Zhang, Zhen-Feng Chen, Kun Hu, Yan-Cheng Liu, Xia Chen, and Hong Liang

State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Chemical Engineering of Guangxi Normal University, Guilin 541004, China

Received 1 October 2012; Accepted 3 January 2013

Academic Editor: Concepción López

Copyright © 2013 Yan Peng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Jung and S. J. Lippard, “Direct cellular responses to platinum-induced DNA damage,” Chemical Reviews, vol. 107, no. 5, pp. 1387–1407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Rosenberg, L. VanCamp, J. E. Trosko, and V. H. Mansour, “Platinum compounds: a new class of potent antitumour agents,” Nature, vol. 222, no. 5191, pp. 385–386, 1969. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Lovejoy and S. J. Lippard, “Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting,” Dalton Transactions, no. 48, pp. 10651–10659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. G. Hartinger, A. A. Nazarov, S. M. Ashraf, P. J. Dyson, and B. K. Keppler, “Carbohydrate-metal complexes and their potential as anticancer agents,” Current Medicinal Chemistry, vol. 15, no. 25, pp. 2574–2591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. S. Lovejoy, R. C. Todd, S. Zhang et al., “cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: uptake, structure, function, and prospects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 8902–8907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Gibson, “The mechanism of action of platinum anticancer agents—what do we really know about it?” Dalton Transactions, vol. 38, pp. 10681–10689, 2009. View at Publisher · View at Google Scholar
  7. I. Łakomska, H. Kooijman, A. L. Spek, W. Z. Shen, and J. Reedijk, “Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4- triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5′-GMP,” Dalton Transactions, no. 48, pp. 10736–10741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. S. Miguel, M. Roitzsch, L. Yin et al., “On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum,” Dalton Transactions, no. 48, pp. 10774–10786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. R. Jamieson and S. J. Lippard, “Structure, recognition, and processing of cisplatin-DNA adducts,” Chemical Reviews, vol. 99, no. 9, pp. 2467–2498, 1999. View at Google Scholar · View at Scopus
  10. J. Reedijk, “Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?” Chemical Reviews, vol. 99, no. 9, pp. 2499–2510, 1999. View at Google Scholar · View at Scopus
  11. G. Cossa, L. Gatti, F. Zunino, and P. Perego, “Strategies to improve the efficacy of platinum compounds,” Current Medicinal Chemistry, vol. 16, no. 19, pp. 2355–2365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Gabano, M. Ravera, and D. Osella, “The drug targeting and delivery approach applied to Pt-antitumour complexes. A coordination point of view,” Current Medicinal Chemistry, vol. 16, no. 34, pp. 4544–4580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Kelland, “The resurgence of platinum-based cancer chemotherapy,” Nature Reviews Cancer, vol. 7, no. 8, pp. 573–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Campone, J. M. Rademaker-Lakhai, J. Bennouna et al., “Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients,” Cancer Chemotherapy and Pharmacology, vol. 60, no. 4, pp. 523–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. N. Sternberg, P. Whelan, J. Hetherington et al., “Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer,” Oncology, vol. 68, no. 1, pp. 2–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. D. Hall, H. R. Mellor, R. Callaghan, and T. W. Hambley, “Basis for design and development of platinum(IV) anticancer complexes,” Journal of Medicinal Chemistry, vol. 50, no. 15, pp. 3403–3411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Lebwohl and R. Canetta, “Clinical development of platinum complexes in cancer therapy: an historical perspective and an update,” European Journal of Cancer, vol. 34, no. 10, pp. 1522–1534, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Rabik and M. E. Dolan, “Molecular mechanisms of resistance and toxicity associated with platinating agents,” Cancer Treatment Reviews, vol. 33, no. 1, pp. 9–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. B. Weiss and M. C. Christian, “New cisplatin analogues in development: a review,” Drugs, vol. 46, no. 3, pp. 360–377, 1993. View at Google Scholar · View at Scopus
  20. E. Wong and C. M. Giandomenico, “Current status of platinum-based antitumor drugs,” Chemical Reviews, vol. 99, pp. 2451–2466, 1999. View at Publisher · View at Google Scholar
  21. G. Hata, Y. Kitano, T. Kaneko, H. Kawai, and M. Mutoh, “Synthesis, structure and antitumor of a water-soluble platinum complex, (1R, 3R, 4R, 5R)-(-)-Quinato(1R, 2R-cyclohexanediamine)platinum(II),” Chemical and Pharmaceutical Bulletin, vol. 40, pp. 1604–1605, 1992. View at Publisher · View at Google Scholar
  22. H. Kawai, Y. Kitano, M. Mutoh, and G. Hata, “Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R, 2R-Cyclohexanediamine-N, N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2]platinum(II),” Chemical and Pharmaceutical Bulletin, vol. 41, pp. 357–361, 1993. View at Publisher · View at Google Scholar
  23. D. L. Ma, T. Y. T. Shum, F. Zhang, C. M. Che, and M. Yang, “Water soluble luminescent platinum terpyridine complexes with glycosylated acetylide and arylacetylide ligands: photoluminescent properties and cytotoxicities,” Chemical Communications, no. 37, pp. 4675–4677, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. D. N ’Da and E. W. Neuse, “Water-soluble macromolecular platinum conjugates derived from 1,2-dihydroxyl-functionalized carrier polymers,” Journal of Inorganic and Organometallic Polymers, vol. 20, pp. 468–477, 2010. View at Publisher · View at Google Scholar
  25. J. Bariyanga, M. T. Johnson, E. M. Mmutlane, and E. W. Neuse, “A water-soluble polyamide containing cis-dicarboxylato-chelated platinum(II),” Journal of Inorganic and Organometallic Polymers, vol. 15, no. 3, pp. 335–340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Song, Y. S. Kim, and Y. S. Sohn, “Synthesis and selective tumor targeting properties of water soluble porphyrin-Pt(II) conjugates,” Journal of Inorganic Biochemistry, vol. 83, pp. 83–88, 2002. View at Publisher · View at Google Scholar
  27. C. Lottner, R. Knuechel, G. Bernhardt, and H. Brunner, “Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells,” Cancer Letters, vol. 215, no. 2, pp. 167–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Benedetti, D. Antonucci, D. Migoni, V. M. Vecchio, C. Ducani, and F. P. Fanizzi, “Water-soluble organometallic analogues of oxaliplatin with cytotoxic and anticlonogenic activity,” ChemMedChem, vol. 5, no. 1, pp. 46–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Horvath, T. Premkumar, A. Boztas, E. Lee, S. Jon, and K. E. Geckeler, “Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-Dichloro(dipyridine)platinum(II) by complexation with β-cyclodextrin,” Molecular Pharmaceutics, vol. 5, pp. 358–363, 2008. View at Publisher · View at Google Scholar
  30. A. Pasini and F. Zunino, “New cisplatin analogues-on the way to better antitumor agents,” Angewandte Chemie, vol. 26, pp. 615–624, 1987. View at Publisher · View at Google Scholar
  31. S. Moradell, J. Lorenzo, A. Rovira et al., “Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5′-GMP and DNA,” Journal of Inorganic Biochemistry, vol. 98, pp. 1933–1946, 2004. View at Publisher · View at Google Scholar
  32. C. G. Hartinger, A. A. Nazarov, S. M. Ashraf, P. J. Dyson, and B. K. Keppler, “Carbohydrate-metal complexes and their potential as anticancer agents,” Current Medicinal Chemistry, vol. 15, pp. 2574–2591, 2008. View at Publisher · View at Google Scholar
  33. Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, and P. G. Wang, “A carbohydrate-linked cisplatin analogue having antitumor activity,” Angewandte Chemie, vol. 38, pp. 1768–1769, 1999. View at Google Scholar
  34. Y. Chen, A. Janczuk, X. Chen, J. Wang, M. Ksebati, and P. G. Wang, “Expeditious syntheses of two carbohydrate-linked cisplatin analogs,” Carbohydrate Research, vol. 337, no. 11, pp. 1043–1046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Mikata, Y. Shinohara, K. Yoneda et al., “Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes,” Bioorganic & Medicinal Chemistry Letters, vol. 11, pp. 3045–3047, 2001. View at Publisher · View at Google Scholar
  36. M. V. De Almeida, E. T. Cesar, A. P. S. Fontes, and E. De C. A. Felicio, “Synthesis of platinum complexes from sugar derivatives,” Journal of Carbohydrate Chemistry, vol. 19, pp. 323–329, 2000. View at Publisher · View at Google Scholar
  37. R. Srinivas, P. P. Karmali, D. Pramanik et al., “Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as dna vaccine carrier in dendritic cell based genetic immunization,” Journal of Medicinal Chemistry, vol. 53, pp. 1387–1391, 2010. View at Publisher · View at Google Scholar
  38. C. Schweinsberg, V. Maes, L. Brans et al., “Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors,” Bioconjugate Chemistry, vol. 19, pp. 2432–2439, 2008. View at Publisher · View at Google Scholar
  39. V. Maes, E. Garcia-Garayoa, P. Blauenstein, and D. Tourwe, “Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties,” Journal of Medicinal Chemistry, vol. 49, pp. 1833–1836, 2006. View at Publisher · View at Google Scholar
  40. E. Garcia-Garayoa, C. Schweinsberg, V. Maes et al., “New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors,” The Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 51, pp. 42–50, 2007. View at Google Scholar
  41. N. Farrell, J. D. Roberts, and M. P. Hacker, “Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation,” Journal of Inorganic Biochemistry, vol. 42, pp. 237–246, 1991. View at Publisher · View at Google Scholar
  42. R. J. Holmes, M. J. McKeage, V. Murry, W. A. Denny, and W. D. McFadyen, “cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro,” Journal of Inorganic Biochemistry, vol. 85, pp. 209–217, 2001. View at Publisher · View at Google Scholar
  43. H. H. Lee, B. D. Palmer, B. C. Baguley et al., “DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane) dichloroplatinum (II),” Journal of Medicinal Chemistry, vol. 35, no. 16, pp. 2983–2987, 1992. View at Google Scholar · View at Scopus
  44. S. Rajagopal and A. F. Spatola, “Mechanism of palladium-catalyzed transfer hydrogenolysis of aryl chlorides by formate salts,” The Journal of Organic Chemistry, vol. 60, pp. 1347–1355, 1995. View at Publisher · View at Google Scholar
  45. L. M. Sun, Z. L. Meng, and J. A. Guo, “Application of ammonium formate in catalytic transfer hydrogenation,” Chemical Reagents, vol. 27, pp. 279–282, 2005. View at Google Scholar
  46. M. Tollabi, E. Framery, C. Goux-Henry, and D. Sinou, “Palladium-catalyzed asymmetric allylic alkylation using chiral glucosamine-based monophosphines,” Tetrahedron Asymmetry, vol. 14, no. 21, pp. 3329–3333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. V. D. adhav and F. P. Schmidtchen, “A novel synthesis of chiral guanidinium receptors and their use in unfolding the energetics of enantiorecognition of chiral carboxylates,” The Journal of Organic Chemistry, vol. 73, pp. 1077–1087, 2008. View at Publisher · View at Google Scholar
  48. M. L. Bowen, Z. -F. Chen, A. M. Roos et al., “Long-chain rhenium and technetium glucosamine conjugates,” Dalton Transactions, vol. 38, pp. 9228–9236, 2009. View at Publisher · View at Google Scholar
  49. Z. F. Chen, X. Y. Song, Y. Peng, Y. C. Liu, and H. Liang, “High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides,” Dalton Transactions, vol. 40, pp. 1684–1692, 2011. View at Publisher · View at Google Scholar
  50. H. C. Clark, A. B. Goel, R. G. Goel, and S. Goel, “Preparation and characterization of platinum(II) complexes Pt(P-C)LX, where (P-C) is metalated tri-tert-butylphosphine,” Inorganic Chemistry, vol. 19, pp. 3220–3225, 1980. View at Publisher · View at Google Scholar
  51. J. Ruiz, V. Rodríguez, N. Cutillas, A. Espinosa, and M. J. Hannon, “Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant,” Journal of Inorganic Biochemistry, vol. 105, pp. 525–531, 2011. View at Publisher · View at Google Scholar
  52. J. A. Platts, G. Ermondi, G. Caron et al., “Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes,” Journal of Biological Inorganic Chemistry, vol. 16, no. 3, pp. 361–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Francisco, S. Gama, F. Mendes et al., “Pt(ii) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies,” Dalton Transactions, vol. 40, no. 21, pp. 5781–5792, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. M. R. Reithofer, A. K. Bytzek, S. M. Valiahdi et al., “Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes,” Journal of Inorganic Biochemistry, vol. 105, no. 1, pp. 46–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Biersack, A. Dietrich, M. Zoldakova et al., “Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells,” Journal of Inorganic Biochemistry, vol. 105, pp. 1630–1637, 2011. View at Publisher · View at Google Scholar
  56. I. Buß, D. Garmann, M. Galanski et al., “Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?” Journal of Inorganic Biochemistry, vol. 105, no. 5, pp. 709–717, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. I. V. Tetko, I. Jaroszewicz, J. A. Platts, and J. Kuduk-Jawworska, “Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods,” Journal of Inorganic Biochemistry, vol. 102, pp. 1424–1437, 2008. View at Publisher · View at Google Scholar
  58. H. Varbanov, S. M. Valiahdi, A. A. Legin et al., “Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin,” European Journal of Medicinal Chemistry, vol. 46, pp. 5456–5464, 2011. View at Publisher · View at Google Scholar
  59. A. M. J. Fichtinger-Schepman, J. L. VanderVeer, J. H. J. Denhartog, P. H. M. Lohman, and J. Reedijk, “Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation,” Biochemistry, vol. 24, pp. 707–713, 1985. View at Publisher · View at Google Scholar
  60. M. S. Robillard, M. Galanski, W. Zimmermann, B. K. Keppler, and J. Reedijk, “(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5′-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity,” Journal of Inorganic Biochemistry, vol. 88, pp. 254–259, 2002. View at Publisher · View at Google Scholar
  61. D. Lemaire, M. H. Fouchet, and J. Kozelka, “Effect of platinum N7-binding to deoxyguanosine and deoxyadenosine on the H8 and H2 chemical shifts. A quantitative analysis,” Journal of Inorganic Biochemistry, vol. 53, pp. 261–271, 1994. View at Publisher · View at Google Scholar
  62. S. Moradell, J. Lorenzo, A. Rovira et al., “Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5′-GMP and DNA,” Journal of Inorganic Biochemistry, vol. 98, pp. 1933–1946, 2004. View at Publisher · View at Google Scholar
  63. F. J. Dijt, G. W. Canters, J. H. J. Den Hartog, and A. T. M. Reedijk, “Reaction products of cis-diammineplatinum(II) compounds with 5'-guanosine monophosphate characterized by high-frequency proton NMR,” Journal of the American Chemical Society, vol. 106, pp. 3644–3647, 1984. View at Publisher · View at Google Scholar
  64. T. Li, H. Lin, and Z. Guo, “Binuclear monofunctional platinum(II) complexes formed by hexaazamacrocyclic bisdien ligands: crystal structure, DNA binding and cytotoxicity studies,” Inorganica Chimica Acta, vol. 362, pp. 967–974, 2009. View at Publisher · View at Google Scholar
  65. S. K. Miller and L. G. Marzilli, “Interaction of platinum antitumor agents with guanine nucleosides and nucleotides. Platinum-195 and proton NMR spectroscopic characterization of compound III,” Inorganic Chemistry, vol. 24, pp. 2421–2425, 1985. View at Publisher · View at Google Scholar
  66. E. R. Jamieson and S. J. Lippard, “Structure, recognition, and processing of cisplatin−DNA adducts,” Chemical Reviews, vol. 99, pp. 2467–2498, 1999. View at Publisher · View at Google Scholar